Spots Global Cancer Trial Database for ganciclovir
Every month we try and update this database with for ganciclovir cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma | NCT00005057 | Melanoma (Skin) | adenovirus RSV-... ganciclovir | 18 Years - | National Cancer Institute (NCI) | |
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies | NCT00917826 | EBV Lymphomas Lympho-prolifer... | Arginine Butyra... Ganciclovir Valganciclovir | 3 Years - | HemaQuest Pharmaceuticals Inc. | |
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma | NCT02202564 | Liver Cancer Hepatocellular ... | LT ADV-TK ganciclovir | 18 Years - 70 Years | Huazhong University of Science and Technology | |
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma | NCT02761291 | Nasopharyngeal ... | Gemcitabine Valproic acid Valganciclovir | 20 Years - 80 Years | Chang Gung Memorial Hospital | |
Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | NCT00005025 | Fallopian Tube ... Ovarian Cancer Primary Periton... | herpes simplex ... ganciclovir | 18 Years - | National Cancer Institute (NCI) | |
Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma | NCT00005057 | Melanoma (Skin) | adenovirus RSV-... ganciclovir | 18 Years - | National Cancer Institute (NCI) | |
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma | NCT00006480 | Neuroblastoma | aldesleukin therapeutic aut... chemotherapy ganciclovir | 1 Year - 17 Years | Fred Hutchinson Cancer Center | |
Gene Therapy for the Treatment of Brain Tumors | NCT00001328 | Brain Neoplasm Neoplasm Metast... | Cytovene (Ganci... G1TKSVNa.53 Pro... | 19 Years - | National Institutes of Health Clinical Center (CC) | |
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma | NCT00006480 | Neuroblastoma | aldesleukin therapeutic aut... chemotherapy ganciclovir | 1 Year - 17 Years | Fred Hutchinson Cancer Center | |
Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | NCT00005025 | Fallopian Tube ... Ovarian Cancer Primary Periton... | herpes simplex ... ganciclovir | 18 Years - | National Cancer Institute (NCI) | |
Gene Therapy for the Treatment of Brain Tumors | NCT00001328 | Brain Neoplasm Neoplasm Metast... | Cytovene (Ganci... G1TKSVNa.53 Pro... | 19 Years - | National Institutes of Health Clinical Center (CC) | |
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma | NCT02202564 | Liver Cancer Hepatocellular ... | LT ADV-TK ganciclovir | 18 Years - 70 Years | Huazhong University of Science and Technology |